2,2,4,6,7-Pentamethyl-2,3-dihydrobenzofuran-5-sulfonamide, 95.0%, 250mg

2-Cyano-N-(2,3-dichloro-phenyl)-acetamide, 1g

2-(3-((3-Bromophenoxy)methyl)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g

Salicylic acid benzyl ester, min. 99%, 100 ml, glass packaging

(1S,2S,4S,5S)-2,5-Bis(3,5-di-tert-butyl-2-hydroxybenzylideneamino)bicyclo[2.2.1]heptane>98.0%(HPLC)(N)100mg

3,4-Dimethoxybenzoylacetonitrile, 95.0%, 25g

4-(3,5-Dimethyl-1H-pyrazol-1-yl)benzonitrile, 98%, 25g

7-Bromo-2,3-dihydro-[1,4]dioxino[2,3-b]pyridine, 95.0%, 250mg

2-Butanone, 3-(phenylmethoxy)-, 95%, 100mg

[2-(4-ethyl-4H-1,2,4-triazol-3-yl)ethyl]amine dihydrochloride hydrate, 95.0%, 1g

6-Fluoro-1-tetralone, 95.0%, 10g

2-[(tert-butylsulfanyl)methyl]pyrrolidine hydrochloride, 95.0%, 500mg

6-(Thiophen-2-yl)-1H-indazole, 95.0%, 250mg